- Home
- DGHI vs VTVT Comparison
DGHI vs VTVT Comparison
Compare DGHI & VTVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DGHI
- VTVT
- Stock Information
- Founded
- DGHI 2017
- VTVT 2015
- Country
- DGHI United States
- VTVT United States
- Employees
- DGHI N/A
- VTVT N/A
- Industry
- DGHI Finance: Consumer Services
- VTVT Biotechnology: Pharmaceutical Preparations
- Sector
- DGHI Finance
- VTVT Health Care
- Exchange
- DGHI Nasdaq
- VTVT Nasdaq
- Market Cap
- DGHI 32.6M
- VTVT 31.9M
- IPO Year
- DGHI N/A
- VTVT 2015
- Fundamental
- Price
- DGHI $1.92
- VTVT $15.64
- Analyst Decision
- DGHI Strong Buy
- VTVT
- Analyst Count
- DGHI 1
- VTVT 0
- Target Price
- DGHI $2.50
- VTVT N/A
- AVG Volume (30 Days)
- DGHI 271.0K
- VTVT 48.4K
- Earning Date
- DGHI 11-15-2024
- VTVT 11-12-2024
- Dividend Yield
- DGHI N/A
- VTVT N/A
- EPS Growth
- DGHI N/A
- VTVT N/A
- EPS
- DGHI N/A
- VTVT N/A
- Revenue
- DGHI $38,327,380.00
- VTVT $1,000,000.00
- Revenue This Year
- DGHI N/A
- VTVT N/A
- Revenue Next Year
- DGHI N/A
- VTVT N/A
- P/E Ratio
- DGHI N/A
- VTVT N/A
- Revenue Growth
- DGHI 97.65
- VTVT 11011.11
- 52 Week Low
- DGHI $0.84
- VTVT $7.38
- 52 Week High
- DGHI $2.54
- VTVT $30.99
- Technical
- Relative Strength Index (RSI)
- DGHI 61.73
- VTVT 60.33
- Support Level
- DGHI $1.60
- VTVT $12.62
- Resistance Level
- DGHI $2.20
- VTVT $15.40
- Average True Range (ATR)
- DGHI 0.25
- VTVT 0.85
- MACD
- DGHI 0.04
- VTVT 0.12
- Stochastic Oscillator
- DGHI 65.96
- VTVT 92.13
About DGHI Digihost Technology Inc. Common Subordinate Voting Shares
Digihost Technology Inc is a blockchain company focused on Bitcoin mining. The company's mining facility is located in Buffalo, New York, and is equipped with an 18.7 MVA 115,000-kilovolt ampere outdoor substation with an option to increase the power output to 42MVA.
About VTVT vTv Therapeutics Inc.
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Itsproduct pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.